Mutations remote from the human gonadotropin-releasing hormone (GnRH) receptor-binding sites specifically increase binding affinity for GnRH II but not GnRH I: evidence for ligand-selective, receptor-active conformations - PubMed (original) (raw)
. 2005 Aug 19;280(33):29796-803.
doi: 10.1074/jbc.M413520200. Epub 2005 Jun 20.
Affiliations
- PMID: 15967801
- DOI: 10.1074/jbc.M413520200
Free article
Mutations remote from the human gonadotropin-releasing hormone (GnRH) receptor-binding sites specifically increase binding affinity for GnRH II but not GnRH I: evidence for ligand-selective, receptor-active conformations
Zhi-Liang Lu et al. J Biol Chem. 2005.
Free article
Abstract
The human gonadotropin-releasing hormone (GnRH) receptor is evolutionarily configured for high affinity binding of GnRH I ([Tyr(5),Leu(7),Arg(8)]GnRH) but at lower affinity for GnRH II ([His(5),Trp(7),Tyr(8)]GnRH). GnRH I is more potent in the activation of the G(q/11) protein in the gonadotrope; however, GnRH II is more potent in the stimulation of apoptosis and antiproliferative effects through activating G(i) protein-mediated signaling, implying that GnRH I and II selectively stabilize different receptor-active conformations that preferentially couple to different signaling pathways. Receptor activation involves ligand induction or conformational selection, but the molecular basis of the communication between ligand-binding sites and receptor allosteric sites remains unclear. We have sought conformational coupling between receptor-ligand intermolecular interactions and intramolecular interaction networks in the human GnRH receptor by mutating remote residues that induce differential ligand binding affinity shifts for GnRH I and II. We have demonstrated that certain Ala mutations in the intracellular segments of transmembrane domains 3 (Met(132)), 5 (Met(227)), 6 (Phe(272) and Phe(276)), and 7 (Ile(322) and Tyr(323)) of the human GnRH receptor allosterically increased ligand binding affinity for GnRH II but had little effect on GnRH I binding affinity. We examined the role of the three amino acids that differ in these two ligands, and we found that Tyr(8) in GnRH II plays a dominant role for the increased affinity of the receptor mutants for GnRH II. We propose that creation of a high affinity binding site for GnRH II accompanies receptor conformational changes, i.e."induced fit" or "conformational selection," mainly determined by the intermolecular interactions between Tyr(8) and the receptor contact residues, which can be facilitated by disruption of particular sets of receptor-stabilizing intramolecular interactions. The findings suggest that GnRH I and II binding may selectively stabilize different receptor-active conformations and therefore different ligand-induced selective signaling described previously for these ligands.
Similar articles
- Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding.
Flanagan CA, Manilall A. Flanagan CA, et al. Front Endocrinol (Lausanne). 2017 Oct 24;8:274. doi: 10.3389/fendo.2017.00274. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 29123501 Free PMC article. Review. - Role of the transmembrane domain 4/extracellular loop 2 junction of the human gonadotropin-releasing hormone receptor in ligand binding and receptor conformational selection.
Forfar R, Lu ZL. Forfar R, et al. J Biol Chem. 2011 Oct 7;286(40):34617-26. doi: 10.1074/jbc.M111.240341. Epub 2011 Aug 10. J Biol Chem. 2011. PMID: 21832286 Free PMC article. - Structural determinants for ligand-receptor conformational selection in a peptide G protein-coupled receptor.
Lu ZL, Coetsee M, White CD, Millar RP. Lu ZL, et al. J Biol Chem. 2007 Jun 15;282(24):17921-9. doi: 10.1074/jbc.M610413200. Epub 2007 Apr 23. J Biol Chem. 2007. PMID: 17452338 - Gonadotropin-releasing hormone receptors.
Millar RP, Lu ZL, Pawson AJ, Flanagan CA, Morgan K, Maudsley SR. Millar RP, et al. Endocr Rev. 2004 Apr;25(2):235-75. doi: 10.1210/er.2003-0002. Endocr Rev. 2004. PMID: 15082521 Review.
Cited by
- Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding.
Flanagan CA, Manilall A. Flanagan CA, et al. Front Endocrinol (Lausanne). 2017 Oct 24;8:274. doi: 10.3389/fendo.2017.00274. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 29123501 Free PMC article. Review. - GnRH signaling, the gonadotrope and endocrine control of fertility.
Bliss SP, Navratil AM, Xie J, Roberson MS. Bliss SP, et al. Front Neuroendocrinol. 2010 Jul;31(3):322-40. doi: 10.1016/j.yfrne.2010.04.002. Epub 2010 May 6. Front Neuroendocrinol. 2010. PMID: 20451543 Free PMC article. Review. - Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.
Kenakin T, Miller LJ. Kenakin T, et al. Pharmacol Rev. 2010 Jun;62(2):265-304. doi: 10.1124/pr.108.000992. Epub 2010 Apr 14. Pharmacol Rev. 2010. PMID: 20392808 Free PMC article. Review. - Noninvasive analytical estimation of endogenous GnRH drive: analysis using graded competitive GnRH-receptor antagonism and a calibrating pulse of exogenous GnRH.
Keenan DM, Clarke IJ, Veldhuis JD. Keenan DM, et al. Endocrinology. 2011 Dec;152(12):4882-93. doi: 10.1210/en.2011-1461. Epub 2011 Oct 25. Endocrinology. 2011. PMID: 22028450 Free PMC article. - Cytotoxic Activity of Novel GnRH Analogs Conjugated with Mitoxantrone in Ovarian Cancer Cells.
Markatos C, Biniari G, Chepurny OG, Karageorgos V, Tsakalakis N, Komontachakis G, Vlata Z, Venihaki M, Holz GG, Tselios T, Liapakis G. Markatos C, et al. Molecules. 2024 Aug 30;29(17):4127. doi: 10.3390/molecules29174127. Molecules. 2024. PMID: 39274973 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous